Two Sigma Securities, LLC Orgenesis Inc. Transaction History

Two Sigma Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.31 - $3.72 $33,938 - $54,654	-14,692 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.61 - $4.9 $38,346 - $71,990	14,692 New	14,692 $42,000
Q2 2019 Aug 14, 2019	SELL	$3.86 - $5.2 $49,527 - $66,721	-12,831 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.28 - $5.6 $54,916 - $71,853	12,831 New	12,831 $68,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.